Codagenix Inc. is a clinical stage biotechnology company leading a new era of live vaccines and viral therapeutics. The company’s breakthrough platform brings together live-attenuated virus design with cutting-edge codon deoptimization for powerful synthetic biology-based solutions to take on our biggest threats in infectious disease, cancer and animal health. Codagenix represents the next wave in vaccine technology, untethered from traditional, time-consuming and unpredictable approaches to attenuating viruses. Current Areas of focus are: - Dengue Fever - Influenza - Yellow Fever - Polio - RSV - COVID-19 - Zika - Cancer Virotherapeutics - Animal Health
Looking for a particular Codagenix Inc. employee's phone or email?
The Codagenix Inc. annual revenue was $1 million in 2026.
Jeffrey Fu is the Chief Business Officer of Codagenix Inc..
9 people are employed at Codagenix Inc..
Codagenix Inc. is based in Farmingdale, New York.
The NAICS codes for Codagenix Inc. are [32541, 3254, 325, 325414, 32].
The SIC codes for Codagenix Inc. are [28, 283].